![Cytotoxicity of ALECSAT on a range of cell types. (A) The percentage of... | Download Scientific Diagram Cytotoxicity of ALECSAT on a range of cell types. (A) The percentage of... | Download Scientific Diagram](https://www.researchgate.net/publication/321428907/figure/fig3/AS:570231617998849@1512965220906/Cytotoxicity-of-ALECSAT-on-a-range-of-cell-types-A-The-percentage-of-remaining-cells.png)
Cytotoxicity of ALECSAT on a range of cell types. (A) The percentage of... | Download Scientific Diagram
![Advances in local therapy for glioblastoma — taking the fight to the tumour | Nature Reviews Neurology Advances in local therapy for glioblastoma — taking the fight to the tumour | Nature Reviews Neurology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41582-022-00621-0/MediaObjects/41582_2022_621_Fig2_HTML.png)
Advances in local therapy for glioblastoma — taking the fight to the tumour | Nature Reviews Neurology
![Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment](https://www.mdpi.com/cancers/cancers-12-01960/article_deploy/html/images/cancers-12-01960-g003.png)
Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
![Cancers | Free Full-Text | Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy? Cancers | Free Full-Text | Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?](https://www.mdpi.com/cancers/cancers-10-00492/article_deploy/html/images/cancers-10-00492-ag.png)
Cancers | Free Full-Text | Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
![Cells | Free Full-Text | Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies Cells | Free Full-Text | Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies](https://www.mdpi.com/cells/cells-11-00116/article_deploy/html/images/cells-11-00116-g001.png)
Cells | Free Full-Text | Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies
![Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment](https://www.mdpi.com/cancers/cancers-12-01960/article_deploy/html/images/cancers-12-01960-g002.png)
Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
![PDF) A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma PDF) A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma](https://i1.rgstatic.net/publication/355512801_A_randomized_phase_II_trial_of_efficacy_and_safety_of_the_immunotherapy_ALECSAT_as_an_adjunct_to_radiotherapy_and_temozolomide_for_newly_diagnosed_glioblastoma/links/619f58a83068c54fa51c5824/largepreview.png)
PDF) A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma
![Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment](https://www.mdpi.com/cancers/cancers-12-01960/article_deploy/html/images/cancers-12-01960-g001.png)
Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
![EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood | Nature Reviews Clinical Oncology EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-020-00447-z/MediaObjects/41571_2020_447_Fig1_HTML.png)
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood | Nature Reviews Clinical Oncology
![Advances in local therapy for glioblastoma — taking the fight to the tumour | Nature Reviews Neurology Advances in local therapy for glioblastoma — taking the fight to the tumour | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41582-022-00621-0/MediaObjects/41582_2022_621_Fig1_HTML.png)
Advances in local therapy for glioblastoma — taking the fight to the tumour | Nature Reviews Neurology
![Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells - ScienceDirect Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S147655861730369X-gr2.jpg)
Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells - ScienceDirect
![Frontiers | Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We? Frontiers | Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?](https://www.frontiersin.org/files/Articles/634031/fimmu-12-634031-HTML-r1/image_m/fimmu-12-634031-t001.jpg)
Frontiers | Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
![Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells - ScienceDirect Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S147655861730369X-gr3.jpg)
Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells - ScienceDirect
![Brain Sciences | Free Full-Text | Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I) Brain Sciences | Free Full-Text | Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I)](https://www.mdpi.com/brainsci/brainsci-11-00386/article_deploy/html/images/brainsci-11-00386-g004.png)
Brain Sciences | Free Full-Text | Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I)
![Cells | Free Full-Text | Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies Cells | Free Full-Text | Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies](https://www.mdpi.com/cells/cells-11-00116/article_deploy/html/images/cells-11-00116-ag.png)
Cells | Free Full-Text | Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies
![Tumour treating fields therapy for glioblastoma: current advances and future directions | British Journal of Cancer Tumour treating fields therapy for glioblastoma: current advances and future directions | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-020-01136-5/MediaObjects/41416_2020_1136_Fig1_HTML.png)
Tumour treating fields therapy for glioblastoma: current advances and future directions | British Journal of Cancer
![Strategies of Mesenchymal Invasion of Patient-derived Brain Tumors: Microenvironmental Adaptation | Scientific Reports Strategies of Mesenchymal Invasion of Patient-derived Brain Tumors: Microenvironmental Adaptation | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep24912/MediaObjects/41598_2016_Article_BFsrep24912_Fig1_HTML.jpg)
Strategies of Mesenchymal Invasion of Patient-derived Brain Tumors: Microenvironmental Adaptation | Scientific Reports
![Frontiers | Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We? Frontiers | Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?](https://www.frontiersin.org/files/Articles/634031/fimmu-12-634031-HTML-r1/image_m/fimmu-12-634031-g001.jpg)